[Progress of related targets in LKB1 signaling pathway for non-small cell lung cancer therapy].
Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
Jing
J
Wang
Ruili
R
Han
Diansheng
D
Zhong
D000091162:AMP-Activated Protein Kinase Kinases; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D058990:Molecular Targeted Therapy; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects
D017346:Protein Serine-Threonine Kinases; C109790:STK11 protein, human; D000091162:AMP-Activated Protein Kinase Kinases